How does lipid lowering prevent coronary events? New insights from human imaging trials

Eur Heart J. 2015 Feb 21;36(8):472-4. doi: 10.1093/eurheartj/ehu510. Epub 2015 Jan 8.

Author

Affiliation

¹ Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA plibby@rics.bwh.harvard.edu.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Coronary Artery Disease / drug therapy*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Rosuvastatin Calcium / therapeutic use*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rosuvastatin Calcium

Grants and funding

R01HL080472/HL/NHLBI NIH HHS/United States